Evaluation and Treatment Strategies in Patients with Schizophrenia and Comorbid Depression
- 1 October 2013
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 43 (10), 446-453
- https://doi.org/10.3928/00485713-20131003-05
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorderJournal of Affective Disorders, 2013
- Neuromodulation for treatment-resistant depressionF1000 Medicine Reports, 2012
- Yoga therapy for SchizophreniaInternational Journal of Yoga, 2012
- Schizophrenia – Insight, Depression: A Correlation StudyIndian Journal of Psychological Medicine, 2012
- Association of biomarkers and depressive symptoms in schizophreniaNeuroscience Letters, 2011
- Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trialBMC Psychiatry, 2011
- Interpersonal Psychotherapy for Depression: A Meta-AnalysisAmerican Journal of Psychiatry, 2011
- Treatment of Subsyndromal Depressive Symptoms in Middle-Age and Older Patients With Schizophrenia: Effect of Age on ResponseAmerican Journal of Geriatric Psychiatry, 2010
- Treatment of subsyndromal depressive symptoms in middle‐aged and older adults with schizophrenia: effect on functioningInternational Journal of Geriatric Psychiatry, 2009
- Nutritional therapies for mental disordersNutrition Journal, 2008